APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diabetic Retinopathy (DR) Analysis Software

Compare research editions
View pricing & licenses

Selected research

Industry Research

Diabetic Retinopathy (DR) Analysis Software Industry Research Report 2026

3 June 2026139 pages

Choose your research edition.

Industry ResearchDiabetic Retinopathy (DR) Analysis Software Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Diabetic Retinopathy (DR) Analysis Software Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Diabetic Retinopathy (DR) Analysis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diabetic Retinopathy (DR) Analysis Software Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Diabetic Retinopathy (DR) Analysis Software Market Analysis and Forecast 2026-2032182 pages · $4,950 USD

Market perspective

The global Diabetic Retinopathy (DR) Analysis Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Diabetic Retinopathy (DR) Analysis Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Diabetic Retinopathy (DR) Analysis Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Diabetic Retinopathy (DR) Analysis Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Diabetic Retinopathy (DR) Analysis Software include Evolucare, Vistel, MONA, Eyenuk, Digital Diagnostics, AEYE Health, RetinaLyze System A/S, Retmarker and Remidio Innovative Solutions, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Diabetic Retinopathy (DR) Analysis Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Diabetic Retinopathy (DR) Analysis Software.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Diabetic Retinopathy (DR) Analysis Software Market by Company

Evolucare

Vistel

MONA

Eyenuk

Digital Diagnostics

AEYE Health

RetinaLyze System A/S

Retmarker

Remidio Innovative Solutions

EyRIS

Airdoc

Acer Medical

Optomed

iCare / Thirona Retina

Topcon Healthcare

Wadhwani AI

Toku

Optain Health

Visulytix

SiBionics

NIDEK

Diabetic Retinopathy (DR) Analysis Software Segment by Type

High Accuracy Type: >95%

Medium Accuracy Type: 85%–95%

Basic Accuracy Type: ＜85%

Diabetic Retinopathy (DR) Analysis Software Segment by Application

Large Comprehensive Hospitals

Ophthalmology Hospitals

Diabetes Specialty Clinics

Public Health Screening Programs

Medical Research Institutions

Others

Diabetic Retinopathy (DR) Analysis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetic Retinopathy (DR) Analysis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diabetic Retinopathy (DR) Analysis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetic Retinopathy (DR) Analysis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Diabetic Retinopathy (DR) Analysis Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Type (2021-2026) Table 7. Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Type (2027-2032) Table 9. Global Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Application (2021-2026) Table 11. Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Application (2027-2032) Table 13. Global Diabetic Retinopathy (DR) Analysis Software Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Region (2021-2026) Table 16. Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Region (2027-2032) Table 18. Diabetic Retinopathy (DR) Analysis Software Industry Trends Table 19. Diabetic Retinopathy (DR) Analysis Software Industry Drivers Table 20. Diabetic Retinopathy (DR) Analysis Software Industry Opportunities and Challenges Table 21. Diabetic Retinopathy (DR) Analysis Software Market Restraints Table 22. Global Top Diabetic Retinopathy (DR) Analysis Software Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Players (2021-2026) Table 24. Global Diabetic Retinopathy (DR) Analysis Software Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Diabetic Retinopathy (DR) Analysis Software, Headquarters and Area Served Table 26. Global Diabetic Retinopathy (DR) Analysis Software Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Diabetic Retinopathy (DR) Analysis Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2027-2032) & (US$ Million) Table 45. Evolucare Company Information Table 46. Evolucare Business Overview Table 47. Evolucare Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 48. Evolucare Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 49. Evolucare Recent Developments Table 50. Vistel Company Information Table 51. Vistel Business Overview Table 52. Vistel Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 53. Vistel Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 54. Vistel Recent Developments Table 55. MONA Company Information Table 56. MONA Business Overview Table 57. MONA Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 58. MONA Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 59. MONA Recent Developments Table 60. Eyenuk Company Information Table 61. Eyenuk Business Overview Table 62. Eyenuk Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 63. Eyenuk Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 64. Eyenuk Recent Developments Table 65. Digital Diagnostics Company Information Table 66. Digital Diagnostics Business Overview Table 67. Digital Diagnostics Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 68. Digital Diagnostics Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 69. Digital Diagnostics Recent Developments Table 70. AEYE Health Company Information Table 71. AEYE Health Business Overview Table 72. AEYE Health Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 73. AEYE Health Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 74. AEYE Health Recent Developments Table 75. RetinaLyze System A/S Company Information Table 76. RetinaLyze System A/S Business Overview Table 77. RetinaLyze System A/S Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 78. RetinaLyze System A/S Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 79. RetinaLyze System A/S Recent Developments Table 80. Retmarker Company Information Table 81. Retmarker Business Overview Table 82. Retmarker Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 83. Retmarker Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 84. Retmarker Recent Developments Table 85. Remidio Innovative Solutions Company Information Table 86. Remidio Innovative Solutions Business Overview Table 87. Remidio Innovative Solutions Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 88. Remidio Innovative Solutions Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 89. Remidio Innovative Solutions Recent Developments Table 90. EyRIS Company Information Table 91. EyRIS Business Overview Table 92. EyRIS Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 93. EyRIS Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 94. EyRIS Recent Developments Table 95. Airdoc Company Information Table 96. Airdoc Business Overview Table 97. Airdoc Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 98. Airdoc Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 99. Airdoc Recent Developments Table 100. Acer Medical Company Information Table 101. Acer Medical Business Overview Table 102. Acer Medical Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 103. Acer Medical Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 104. Acer Medical Recent Developments Table 105. Optomed Company Information Table 106. Optomed Business Overview Table 107. Optomed Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 108. Optomed Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 109. Optomed Recent Developments Table 110. iCare / Thirona Retina Company Information Table 111. iCare / Thirona Retina Business Overview Table 112. iCare / Thirona Retina Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 113. iCare / Thirona Retina Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 114. iCare / Thirona Retina Recent Developments Table 115. Topcon Healthcare Company Information Table 116. Topcon Healthcare Business Overview Table 117. Topcon Healthcare Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 118. Topcon Healthcare Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 119. Topcon Healthcare Recent Developments Table 120. Wadhwani AI Company Information Table 121. Wadhwani AI Business Overview Table 122. Wadhwani AI Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 123. Wadhwani AI Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 124. Wadhwani AI Recent Developments Table 125. Toku Company Information Table 126. Toku Business Overview Table 127. Toku Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 128. Toku Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 129. Toku Recent Developments Table 130. Optain Health Company Information Table 131. Optain Health Business Overview Table 132. Optain Health Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 133. Optain Health Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 134. Optain Health Recent Developments Table 135. Visulytix Company Information Table 136. Visulytix Business Overview Table 137. Visulytix Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 138. Visulytix Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 139. Visulytix Recent Developments Table 140. SiBionics Company Information Table 141. SiBionics Business Overview Table 142. SiBionics Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 143. SiBionics Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 144. SiBionics Recent Developments Table 145. NIDEK Company Information Table 146. NIDEK Business Overview Table 147. NIDEK Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) & (US$ Million) Table 148. NIDEK Diabetic Retinopathy (DR) Analysis Software Product Portfolio Table 149. NIDEK Recent Developments Table 150. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Diabetic Retinopathy (DR) Analysis Software Product Image Figure 5. Global Diabetic Retinopathy (DR) Analysis Software Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Type: 2025 VS 2032 Figure 7. High Accuracy Type: >95% Product Figure 8. Medium Accuracy Type: 85%–95% Product Figure 9. Basic Accuracy Type: ＜85% Product Figure 10. Global Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Application: 2025 VS 2032 Figure 12. Large Comprehensive Hospitals Product Figure 13. Ophthalmology Hospitals Product Figure 14. Diabetes Specialty Clinics Product Figure 15. Public Health Screening Programs Product Figure 16. Medical Research Institutions Product Figure 17. Others Product Figure 18. Global Diabetic Retinopathy (DR) Analysis Software Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 19. Global Diabetic Retinopathy (DR) Analysis Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Region: 2025 VS 2032 Figure 21. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Players in 2025 Figure 22. Global Diabetic Retinopathy (DR) Analysis Software Manufacturers Established Date Figure 23. Global Top 5 and 10 Diabetic Retinopathy (DR) Analysis Software Players Market Share by Revenue in 2025 Figure 24. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. North America Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Diabetic Retinopathy (DR) Analysis Software Market Share by Country (2021-2032) Figure 27. United States Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Canada Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Mexico Diabetic Retinopathy (DR) Analysis Software Market Share by Country (2021-2032) Figure 30. Europe Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Diabetic Retinopathy (DR) Analysis Software Market Share by Country (2021-2032) Figure 32. Germany Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. France Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. U.K. Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Italy Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Spain Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Russia Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Netherlands Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Nordic Countries Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Share by Country (2021-2032) Figure 42. China Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Japan Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. South Korea Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. India Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. India Diabetic Retinopathy (DR) Analysis Software Market Share by Country (2021-2032) Figure 47. Australia Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. China Taiwan Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Southeast Asia Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. South America Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. South America Diabetic Retinopathy (DR) Analysis Software Market Share by Country (2021-2032) Figure 52. Brazil Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Argentina Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Chile Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Colombia Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. Peru Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 57. Evolucare Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 58. Vistel Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 59. MONA Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 60. Eyenuk Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 61. Digital Diagnostics Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 62. AEYE Health Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 63. RetinaLyze System A/S Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 64. Retmarker Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 65. Remidio Innovative Solutions Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 66. EyRIS Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 67. Airdoc Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 68. Acer Medical Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 69. Optomed Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 70. iCare / Thirona Retina Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 71. Topcon Healthcare Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 72. Wadhwani AI Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 73. Toku Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 74. Optain Health Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 75. Visulytix Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 76. SiBionics Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026) Figure 77. NIDEK Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)

Scope & coverage.

Types
  • High Accuracy Type: >95%
  • Medium Accuracy Type: 85%–95%
  • Basic Accuracy Type: ＜85%
Applications
  • Large Comprehensive Hospitals
  • Ophthalmology Hospitals
  • Diabetes Specialty Clinics
  • Public Health Screening Programs
  • Medical Research Institutions
  • Others
Companies covered
  • Evolucare
  • Vistel
  • MONA
  • Eyenuk
  • Digital Diagnostics
  • AEYE Health
  • RetinaLyze System A/S
  • Retmarker
  • Remidio Innovative Solutions
  • EyRIS
  • Airdoc
  • Acer Medical
  • Optomed
  • iCare / Thirona Retina
  • Topcon Healthcare
  • Wadhwani AI
  • Toku
  • Optain Health
  • Visulytix
  • SiBionics
  • NIDEK

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Diabetic Retinopathy (DR) Analysis Software by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 High Accuracy Type: >95%
  5. 2.2.3 Medium Accuracy Type: 85%–95%
  6. 2.2.4 Basic Accuracy Type: ＜85%
  7. 2.3 Diabetic Retinopathy (DR) Analysis Software by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  9. 2.3.2 Large Comprehensive Hospitals
  10. 2.3.3 Ophthalmology Hospitals
  11. 2.3.4 Diabetes Specialty Clinics
  12. 2.3.5 Public Health Screening Programs
  13. 2.3.6 Medical Research Institutions
  14. 2.3.7 Others
  15. 2.4 Assumptions and Limitations
3 Diabetic Retinopathy (DR) Analysis Software Breakdown Data by Type
  1. 3.1 Global Diabetic Retinopathy (DR) Analysis Software Historic Market Size by Type (2021-2026)
  2. 3.2 Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Type (2027-2032)
4 Diabetic Retinopathy (DR) Analysis Software Breakdown Data by Application
  1. 4.1 Global Diabetic Retinopathy (DR) Analysis Software Historic Market Size by Application (2021-2026)
  2. 4.2 Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Diabetic Retinopathy (DR) Analysis Software Market Perspective (2021-2032)
  2. 5.2 Global Diabetic Retinopathy (DR) Analysis Software Growth Trends by Region
  3. 5.2.1 Global Diabetic Retinopathy (DR) Analysis Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Diabetic Retinopathy (DR) Analysis Software Historic Market Size by Region (2021-2026)
  5. 5.2.3 Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Region (2027-2032)
  6. 5.3 Diabetic Retinopathy (DR) Analysis Software Market Dynamics
  7. 5.3.1 Diabetic Retinopathy (DR) Analysis Software Industry Trends
  8. 5.3.2 Diabetic Retinopathy (DR) Analysis Software Market Drivers
  9. 5.3.3 Diabetic Retinopathy (DR) Analysis Software Market Challenges
  10. 5.3.4 Diabetic Retinopathy (DR) Analysis Software Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Diabetic Retinopathy (DR) Analysis Software Players by Revenue
  2. 6.1.1 Global Top Diabetic Retinopathy (DR) Analysis Software Players by Revenue (2021-2026)
  3. 6.1.2 Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Diabetic Retinopathy (DR) Analysis Software Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Diabetic Retinopathy (DR) Analysis Software Head Office and Area Served
  6. 6.4 Global Diabetic Retinopathy (DR) Analysis Software Players, Product Type & Application
  7. 6.5 Global Diabetic Retinopathy (DR) Analysis Software Manufacturers Established Date
  8. 6.6 Global Diabetic Retinopathy (DR) Analysis Software Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Diabetic Retinopathy (DR) Analysis Software Market Size (2021-2032)
  2. 7.2 North America Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2021-2026)
  4. 7.4 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Diabetic Retinopathy (DR) Analysis Software Market Size (2021-2032)
  2. 8.2 Europe Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2021-2026)
  4. 8.4 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size (2021-2032)
  2. 9.2 Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Diabetic Retinopathy (DR) Analysis Software Market Size (2021-2032)
  2. 10.2 South America Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2021-2026)
  4. 10.4 South America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size (2021-2032)
  2. 11.2 Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Evolucare
  2. 12.1.1 Evolucare Company Information
  3. 12.1.2 Evolucare Business Overview
  4. 12.1.3 Evolucare Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  5. 12.1.4 Evolucare Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  6. 12.1.5 Evolucare Recent Developments
  7. 12.2 Vistel
  8. 12.2.1 Vistel Company Information
  9. 12.2.2 Vistel Business Overview
  10. 12.2.3 Vistel Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  11. 12.2.4 Vistel Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  12. 12.2.5 Vistel Recent Developments
  13. 12.3 MONA
  14. 12.3.1 MONA Company Information
  15. 12.3.2 MONA Business Overview
  16. 12.3.3 MONA Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  17. 12.3.4 MONA Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  18. 12.3.5 MONA Recent Developments
  19. 12.4 Eyenuk
  20. 12.4.1 Eyenuk Company Information
  21. 12.4.2 Eyenuk Business Overview
  22. 12.4.3 Eyenuk Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  23. 12.4.4 Eyenuk Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  24. 12.4.5 Eyenuk Recent Developments
  25. 12.5 Digital Diagnostics
  26. 12.5.1 Digital Diagnostics Company Information
  27. 12.5.2 Digital Diagnostics Business Overview
  28. 12.5.3 Digital Diagnostics Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  29. 12.5.4 Digital Diagnostics Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  30. 12.5.5 Digital Diagnostics Recent Developments
  31. 12.6 AEYE Health
  32. 12.6.1 AEYE Health Company Information
  33. 12.6.2 AEYE Health Business Overview
  34. 12.6.3 AEYE Health Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  35. 12.6.4 AEYE Health Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  36. 12.6.5 AEYE Health Recent Developments
  37. 12.7 RetinaLyze System A/S
  38. 12.7.1 RetinaLyze System A/S Company Information
  39. 12.7.2 RetinaLyze System A/S Business Overview
  40. 12.7.3 RetinaLyze System A/S Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  41. 12.7.4 RetinaLyze System A/S Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  42. 12.7.5 RetinaLyze System A/S Recent Developments
  43. 12.8 Retmarker
  44. 12.8.1 Retmarker Company Information
  45. 12.8.2 Retmarker Business Overview
  46. 12.8.3 Retmarker Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  47. 12.8.4 Retmarker Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  48. 12.8.5 Retmarker Recent Developments
  49. 12.9 Remidio Innovative Solutions
  50. 12.9.1 Remidio Innovative Solutions Company Information
  51. 12.9.2 Remidio Innovative Solutions Business Overview
  52. 12.9.3 Remidio Innovative Solutions Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  53. 12.9.4 Remidio Innovative Solutions Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  54. 12.9.5 Remidio Innovative Solutions Recent Developments
  55. 12.10 EyRIS
  56. 12.10.1 EyRIS Company Information
  57. 12.10.2 EyRIS Business Overview
  58. 12.10.3 EyRIS Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  59. 12.10.4 EyRIS Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  60. 12.10.5 EyRIS Recent Developments
  61. 12.11 Airdoc
  62. 12.11.1 Airdoc Company Information
  63. 12.11.2 Airdoc Business Overview
  64. 12.11.3 Airdoc Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  65. 12.11.4 Airdoc Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  66. 12.11.5 Airdoc Recent Developments
  67. 12.12 Acer Medical
  68. 12.12.1 Acer Medical Company Information
  69. 12.12.2 Acer Medical Business Overview
  70. 12.12.3 Acer Medical Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  71. 12.12.4 Acer Medical Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  72. 12.12.5 Acer Medical Recent Developments
  73. 12.13 Optomed
  74. 12.13.1 Optomed Company Information
  75. 12.13.2 Optomed Business Overview
  76. 12.13.3 Optomed Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  77. 12.13.4 Optomed Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  78. 12.13.5 Optomed Recent Developments
  79. 12.14 iCare / Thirona Retina
  80. 12.14.1 iCare / Thirona Retina Company Information
  81. 12.14.2 iCare / Thirona Retina Business Overview
  82. 12.14.3 iCare / Thirona Retina Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  83. 12.14.4 iCare / Thirona Retina Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  84. 12.14.5 iCare / Thirona Retina Recent Developments
  85. 12.15 Topcon Healthcare
  86. 12.15.1 Topcon Healthcare Company Information
  87. 12.15.2 Topcon Healthcare Business Overview
  88. 12.15.3 Topcon Healthcare Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  89. 12.15.4 Topcon Healthcare Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  90. 12.15.5 Topcon Healthcare Recent Developments
  91. 12.16 Wadhwani AI
  92. 12.16.1 Wadhwani AI Company Information
  93. 12.16.2 Wadhwani AI Business Overview
  94. 12.16.3 Wadhwani AI Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  95. 12.16.4 Wadhwani AI Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  96. 12.16.5 Wadhwani AI Recent Developments
  97. 12.17 Toku
  98. 12.17.1 Toku Company Information
  99. 12.17.2 Toku Business Overview
  100. 12.17.3 Toku Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  101. 12.17.4 Toku Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  102. 12.17.5 Toku Recent Developments
  103. 12.18 Optain Health
  104. 12.18.1 Optain Health Company Information
  105. 12.18.2 Optain Health Business Overview
  106. 12.18.3 Optain Health Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  107. 12.18.4 Optain Health Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  108. 12.18.5 Optain Health Recent Developments
  109. 12.19 Visulytix
  110. 12.19.1 Visulytix Company Information
  111. 12.19.2 Visulytix Business Overview
  112. 12.19.3 Visulytix Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  113. 12.19.4 Visulytix Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  114. 12.19.5 Visulytix Recent Developments
  115. 12.20 SiBionics
  116. 12.20.1 SiBionics Company Information
  117. 12.20.2 SiBionics Business Overview
  118. 12.20.3 SiBionics Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  119. 12.20.4 SiBionics Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  120. 12.20.5 SiBionics Recent Developments
  121. 12.21 NIDEK
  122. 12.21.1 NIDEK Company Information
  123. 12.21.2 NIDEK Business Overview
  124. 12.21.3 NIDEK Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2021-2026)
  125. 12.21.4 NIDEK Diabetic Retinopathy (DR) Analysis Software Product Portfolio
  126. 12.21.5 NIDEK Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst